Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03118700 · ClinicalTrials.gov registry record · NA

Central Hemodynamic Exercise Responses Study

A NA study, sponsored by Arizona State University.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT03118700: Clinical Trial NA study, sponsored by Arizona State University.

NCT03118700 is a NA study that was terminated before completion, run by Arizona State University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03118700, a NA study, was terminated before completion, sponsored by Arizona State University.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

The purpose of this study is to examine the acute effect of continuous and aerobic interval exercise on postexercise central BP response in men with an elevated blood pressure.

Primary Outcome

After the subject performs both an aerobic interval and continuous exercise, blood pressure will be measured every 10-minutes using an ambulatory blood pressure monitor

Interventions

  • OTHER Aerobic Interval Exercise
  • OTHER Continuous exercise

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2017-03-27
Est. Completion 2017-12
Phase NA
Arizona State University

187 total trials

Why NCT03118700 stopped before completion

NCT03118700 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Aerobic Interval Exercise is the first listed.

NCT03118700 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03118700 about?

NCT03118700 is a clinical study titled "Central Hemodynamic Exercise Responses Study". The purpose of this study is to examine the acute effect of continuous and aerobic interval exercise on postexercise central BP response in men with an elevated blood pressure.

What is the current status of trial NCT03118700?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-03-27. Estimated completion is 2017-12.

What interventions are being tested in trial NCT03118700?

The interventions under investigation include: Aerobic Interval Exercise (OTHER), Continuous exercise (OTHER).

Who is sponsoring clinical trial NCT03118700?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03118700's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03118700, the US trial registry maintained by the National Library of Medicine. NCT03118700 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.